产品
文章
搜索
名称描述内容
产品中心
商品描述
Lymphocyte Medium: also known as human immune cells serum-free basal medium is a serum-free, human immune cell culture medium containing no xeno-free components and can be used for human lymphocytes, CIK, DC, NK, etc. Class immune cell culture, with a high survival rate, killing activity and amplification fold.
Name: GT-T551 Medium for T-Cell Culture and Expansion
product manual:
GT-T551 is a culture medium ideally suited for expansion of human T lymphocytes (T cells). It is supplemented with human albumin (pharmaceutical grade), recombinant human insulin, L-glutamine, and streptomycin; no additional proteins or growth factors are added The medium can support stable growth in the presence or absence of serum.
Anti-CD3 / IL-2 T-cell activation can also be performed in this medium (Wang et al. 2013; Ai et al. 2014; Dodo et al. 2014). When using this activation method, the additional presence of RetroNectin enhances the proliferation of T cells (Yu et al. 2008; Ishikawa et al. 2014; Hosoi et al. 2014; Sakamoto et al. 2015; Li et al. 2015) and results in an expanded cell population that shows a higher proportion of naïve T cells than anti-CD3 antibody stimulation alone (Hosoi et al. 2014). Content and
Name: GT-T551 Medium for T-Cell Culture and Expansion
product manual:
GT-T551 is a culture medium ideally suited for expansion of human T lymphocytes (T cells). It is supplemented with human albumin (pharmaceutical grade), recombinant human insulin, L-glutamine, and streptomycin; no additional proteins or growth factors are added The medium can support stable growth in the presence or absence of serum.
Anti-CD3 / IL-2 T-cell activation can also be performed in this medium (Wang et al. 2013; Ai et al. 2014; Dodo et al. 2014). When using this activation method, the additional presence of RetroNectin enhances the proliferation of T cells (Yu et al. 2008; Ishikawa et al. 2014; Hosoi et al. 2014; Sakamoto et al. 2015; Li et al. 2015) and results in an expanded cell population that shows a higher proportion of naïve T cells than anti-CD3 antibody stimulation alone (Hosoi et al. 2014). Content and
